New wearable device aims to ease jaw pain without drugs
NCT ID NCT07639944
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a wearable device that uses mild electrical pulses to relieve pain from temporomandibular disorders (TMD), which cause jaw, face, and headache pain. About 40 people aged 12 and older with chronic TMD will use the device at home for several weeks. The goal is to see if it safely reduces daily pain and improves jaw function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2026
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Is of 12 years of age and older (inclusive; of any gender, race, or ethnicity) 2. Meets diagnostic criteria for chronic TMD (Myalgia and/or Arthralgia) based on the Diagnostic Criteria for TMD (DC/TMD) 3. Has experienced TMD pain for at least 6 months 4. Has experienced TMD pain at level ≥4 on a 0-10 scale for at least 10 days of the last 30 days 5. Commits to not making any changes to TMD treatment regime (medication and/or non-medication), including not adding or removing treatment, and if on any existing treatment then maintaining the same treatment type, dosage, and frequency from 3 months prior to enrollment to study completion 6. Naïve to REN treatment 7. Willing and able to understand and comply with all study procedures and be available for the duration of the study 8. Has their own smartphone or tablet device that is connected to the internet 9. Provides a signed and dated informed consent form Exclusion Criteria: 1. Has any of the following medical conditions: 1.1 Uncontrolled seizures/epilepsy 1.2 Benign and malignant TMJ and masticatory muscle tumors 1.3 Presence of implanted electrical device 2. Has experienced facial trauma or orofacial surgery within 6 weeks prior to the Screening and Baseline Visit 3. Is undergoing current active orthodontic treatment 4. Currently being treated with chemotherapy or radiation therapy 5. Meets the ICHD-3 diagnostic criteria for migraine with or without aura, either chronic or non-chronic migraine 6. Currently taking an opioid medication, whether episodically or daily, within 30 days prior to the Screening and Baseline Visit 7. Has been treated with another investigational drug or treatment within 30 days prior to the Enrollment Visit 8. Taking more than one prescription drug for the treatment of pain (including all types of drugs and modalities, e.g. pill, spray, injection) Note that this criterion does not refer to drug-free based treatments (including split therapy, physical therapy, acupuncture, massage therapy, biofeedback, CBT, or transcutaneous electrical nerve stimulation) for the treatment of pain, which may be used (single or multiple treatments) as long as not changed throughout the study. 9. Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Temporomandibular disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Proven Endpoints
RECRUITINGRidgeland, Mississippi, 39157, United States
-
True North neurology
RECRUITINGCommack, New York, 11725, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Blood-Derived injection ease jaw pain without surgery?
- Jaw pain and mental health: study probes the hidden link
- Jaw misalignment linked to posture? 3D spine scans investigate
- Could your neck be making your jaw pain worse?
- Sugar pills for pain? new study tests honest placebos for jaw disorder sufferers
- Could a Two-Session video call ease your jaw pain?